Search
NYHA Class I or II heart failure
go.drugbank.com/conditions/DBCOND0025082Drugs: CarvedilolSynonyms: NYHA Class I or II heart failureSigns or symptoms of urinary tract irritation
go.drugbank.com/conditions/DBCOND0099311Drugs: PhenazopyridineSynonyms: Signs or symptoms of urinary tract irritationFilgrastim
go.drugbank.com/drugs/DB00099ApprovedInvestigational[L40719] It has a number of therapeutic uses, including the management and prevention of infections and febrile neutropenia in patients receiving myelosuppressive chemotherapy or radiation therapy. … Filgrastim mimics the biological actions of G-CSF to increase the levels of neutrophils in the blood.
Synonyms: r-metHuG-CSFProducts: Zarzio 30 MU/0.5 ml solution for injection or infusion, Zarzio 48 MU/0.5 ml solution for injection or infusion in pre-filled syringeTechnetium Tc-99m medronate
go.drugbank.com/drugs/DB09138ApprovedInvestigationalIt is composed of a technetium ion complexed with medronic acid, a type of bisphosphonate. … Like other bisphosphonates used in the treatment of osteoporosis, medronic acid binds to the hydroxyapatite crystals within bone, and in this way localizes the drug to bone for delineation of areas of
Categories: Compounds used in a research, industrial, or household setting, Diagnostic Uses of ChemicalsProducts: Kit for the Preparation of Technetium Tc 99M Medronate, Kit for the Preparation of Technetium Tc 99m MedronateMitomycin
go.drugbank.com/drugs/DB00305ApprovedInvestigational[A193419] Mitomycin's cross-linking activity has resulted in its approval for the treatment of a variety of cancers - the most recent of which is an April 2020 approval for its use in low-grade Upper … Mitomycin is an antineoplastic antibiotic first isolated by Japanese microbiologists in the 1950s from cultures of _Streptomyces caespitosus_.
Categories: Compounds used in a research, industrial, or household settingProducts: MITONCO 10mg powder for solution for injection/infusion or intravesical, Mitomycin for InjectionOndansetron
go.drugbank.com/drugs/DB00904ApprovedInvestigationalWithdrawn[L5221] The FDA withdrew its approval for the use of all intravenous drug products containing more than 16 mg of ondansetron hydrochloride in a single dose, due to a high risk of QT prolongation. … orally soluble films that are both discreet in administration and less of a burden in comparison to having patients attempt to swallow pills during emesis.
Categories: Serotonergic Drugs Shown to Increase Risk of Serotonin SyndromeProducts: BRAUN SOLUTION FOR INJECTION OR INFUSION 2 MG/ML, ONDANSETRON SOLUTION FOR INFUSION OR INJECTION 2mg/mLInternal contamination caused by radioactive or non-radioactive thallium
go.drugbank.com/conditions/DBCOND0093569Drugs: Prussian blueSynonyms: Internal contamination caused by radioactive or non-radioactive thalliumLocally Advanced or Metastatic Non-small Cell Lung Cancer
go.drugbank.com/conditions/DBCOND0055934Drugs: RepotrectinibSynonyms: Metastatic or Locally Advanced NSCLC, Locally Advanced or Metastatic NSCLCRelapsed or Refractory Diffuse Large B Cell Lymphoma (DLBCL)
go.drugbank.com/conditions/DBCOND0093009Drugs: GlofitamabSynonyms: Relapsed or Refractory Diffuse Large B-cell Lymphoma, Relapsed or Refractory Diffuse Large B Cell LymphomaHistory of stroke or other cerebrovascular disease cardiovascular event
go.drugbank.com/conditions/DBCOND0122341Drugs: SimvastatinSynonyms: History of stroke or other cerebrovascular disease cardiovascular event, History of stroke or other cerebrovacular disease Cardiovascular Event